π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
To evaluate the efficacy and safety of Relmacabtagene Autoleucel in the tre...
Status
Not Yet Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-12-28
Trial ID
NCT06142188
Treatments Being Tested
To assess the safety tolerability pharmacokinetics and pharmacodynamics of ...
Status
Unknown
Location
Multiple Locations
Start Date
2024-03
Trial ID
NCT06297408
Treatments Being Tested
This is a prospective, single-arm, multicenter, phase II clinical trial to ...
Status
Recruiting
Location
Sun Yat-sen Universitiy Cancer Center
Start Date
2025-09-15
Trial ID
NCT07077512
Treatments Being Tested
This is a phase I, open-label, single-arm, multicenter study to asess the s...
Status
Unknown
Location
Relma-cel Medical
Start Date
2023-02-24
Trial ID
NCT05765006
Treatments Being Tested
Clinical trial for the safety and efficacy of CD19 CAR-T following autologo...
Status
Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2024-04-16
Trial ID
NCT06365671
Treatments Being Tested
This is a single arm, open-label, dose escalation clinical study to evaluat...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2017-11-16
Trial ID
NCT03344367
Treatments Being Tested
The primary objective of this study is to estimate the efficacy of Relmacab...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2023-01-03
Trial ID
NCT05590221
Treatments Being Tested
This is a single arm, open-label, dose escalation clinical study to evaluat...
Status
Unknown
Location
Ruijin hospital
Start Date
2018-01-05
Trial ID
NCT03355859
Treatments Being Tested
To evaluate the efficacy and safety of post-marketing Regiorense injection ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-06-20
Trial ID
NCT05814848
Treatments Being Tested
This is a phase I, open-label, single-arm, multicenter study to assess the ...
Status
Completed
Location
Ruijin hospital
Start Date
2020-07-10
Trial ID
NCT04812691
Treatments Being Tested